LTFS
BIIB icon

Ladenburg Thalmann Financial Services’s Biogen BIIB Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4.12M Buy
15,358
+2,471
+19% +$686K 0.03% 554
2019
Q3 		$3M Buy
12,887
+859
+7% +$200K 0.02% 655
2019
Q2 		$2.82M Buy
12,028
+23
+0.2% +$5.31K 0.02% 667
2019
Q1 		$2.85M Buy
12,005
+721
+6% +$227K 0.02% 631
2018
Q4 		$3.4M Sell
11,284
-214
-2% -$68.3K 0.03% 486
2018
Q3 		$4.06M Buy
11,498
+2,536
+28% +$873K 0.03% 453
2018
Q2 		$2.45M Hold
8,962
– – 0.02% 615
2018
Q1 		$2.45M Sell
8,962
-1,817
-17% -$564K 0.02% 615
2017
Q4 		$3.44M Buy
10,779
+1,230
+13% +$395K 0.03% 476
2017
Q3 		$2.99M Buy
9,549
+544
+6% +$161K 0.03% 471
2017
Q2 		$2.44M Buy
9,005
+19
+0.2% +$5.02K 0.03% 508
2017
Q1 		$2.46M Buy
8,986
+1,243
+16% +$351K 0.03% 489
2016
Q4 		$2.2M Buy
7,743
+2,383
+44% +$706K 0.03% 472
2016
Q3 		$1.68M Sell
5,360
-2,065
-28% -$612K 0.03% 559
2016
Q2 		$1.8M Buy
7,425
+635
+9% +$167K 0.03% 505
2016
Q1 		$1.77M Buy
6,790
+820
+14% +$217K 0.03% 471
2015
Q4 		$1.82M Buy
5,970
+519
+10% +$149K 0.03% 454
2015
Q3 		$1.59M Buy
5,451
+558
+11% +$184K 0.03% 455
2015
Q2 		$1.98M Sell
4,893
-681
-12% -$273K 0.04% 432
2015
Q1 		$2.35M Buy
5,574
+1,085
+24% +$428K 0.05% 379
2014
Q4 		$1.54M Buy
4,489
+1,421
+46% +$460K 0.03% 431
2014
Q3 		$1.02M Buy
3,068
+377
+14% +$124K 0.03% 502
2014
Q2 		$849K Sell
2,691
-2,919
-52% -$879K 0.02% 564
2014
Q1 		$1.84M Buy
5,610
+39
+0.7% +$12.4K 0.05% 286
2013
Q4 		$1.6M Sell
5,571
-295
-5% -$76.3K 0.05% 307
2013
Q3 		$1.31M Buy
5,866
+83
+1% +$18.6K 0.04% 328
2013
Q2 		$1.33M Buy
+5,783
New +$1.24M 0.05% 318

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BIIB Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Biogen (BIIB) stake by 19% in Q4 2019, buying an estimated $686K and bringing the position to 15,358 shares worth $4.12M. The position accounts for 0.03% of the portfolio, ranked #554.

Ladenburg Thalmann Financial Services first reported a position in BIIB in Q2 2013 and has held it in 27 quarters since. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 15,358 shares of Biogen worth $4.12M as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 2,471 Biogen shares in Q4 2019, an estimated $686K.
  • Biogen made up 0.03% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #554 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Biogen in Q2 2013 and has held it in 27 quarters since.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.